EXPO Relative Valuation
EXPO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, EXPO is overvalued; if below, it's undervalued.
Historical Valuation
Exponent Inc (EXPO) is now in the Undervalued zone, suggesting that its current forward PE ratio of 32.05 is considered Undervalued compared with the five-year average of 46.68. The fair price of Exponent Inc (EXPO) is between 87.38 to 119.03 according to relative valuation methord. Compared to the current price of 75.02 USD , Exponent Inc is Undervalued By 14.15%.
Relative Value
Fair Zone
87.38-119.03
Current Price:75.02
14.15%
Undervalued
32.05
PE
1Y
3Y
5Y
21.35
EV/EBITDA
Exponent Inc. (EXPO) has a current EV/EBITDA of 21.35. The 5-year average EV/EBITDA is 32.91. The thresholds are as follows: Strongly Undervalued below 20.56, Undervalued between 20.56 and 26.74, Fairly Valued between 39.09 and 26.74, Overvalued between 39.09 and 45.27, and Strongly Overvalued above 45.27. The current Forward EV/EBITDA of 21.35 falls within the Undervalued range.
23.06
EV/EBIT
Exponent Inc. (EXPO) has a current EV/EBIT of 23.06. The 5-year average EV/EBIT is 35.97. The thresholds are as follows: Strongly Undervalued below 20.36, Undervalued between 20.36 and 28.16, Fairly Valued between 43.77 and 28.16, Overvalued between 43.77 and 51.57, and Strongly Overvalued above 51.57. The current Forward EV/EBIT of 23.06 falls within the Undervalued range.
6.18
PS
Exponent Inc. (EXPO) has a current PS of 6.18. The 5-year average PS is 9.60. The thresholds are as follows: Strongly Undervalued below 5.71, Undervalued between 5.71 and 7.65, Fairly Valued between 11.55 and 7.65, Overvalued between 11.55 and 13.50, and Strongly Overvalued above 13.50. The current Forward PS of 6.18 falls within the Undervalued range.
0.00
P/OCF
Exponent Inc. (EXPO) has a current P/OCF of 0.00. The 5-year average P/OCF is 15.49. The thresholds are as follows: Strongly Undervalued below -23.28, Undervalued between -23.28 and -3.89, Fairly Valued between 34.87 and -3.89, Overvalued between 34.87 and 54.26, and Strongly Overvalued above 54.26. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Exponent Inc. (EXPO) has a current P/FCF of 0.00. The 5-year average P/FCF is 18.37. The thresholds are as follows: Strongly Undervalued below -23.51, Undervalued between -23.51 and -2.57, Fairly Valued between 39.32 and -2.57, Overvalued between 39.32 and 60.26, and Strongly Overvalued above 60.26. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Exponent Inc (EXPO) has a current Price-to-Book (P/B) ratio of 8.70. Compared to its 3-year average P/B ratio of 11.79 , the current P/B ratio is approximately -26.20% higher. Relative to its 5-year average P/B ratio of 12.62, the current P/B ratio is about -31.05% higher. Exponent Inc (EXPO) has a Forward Free Cash Flow (FCF) yield of approximately 3.51%. Compared to its 3-year average FCF yield of 2.56%, the current FCF yield is approximately 36.95% lower. Relative to its 5-year average FCF yield of 2.36% , the current FCF yield is about 48.76% lower.
8.70
P/B
Median3y
11.79
Median5y
12.62
3.51
FCF Yield
Median3y
2.56
Median5y
2.36
Competitors Valuation Multiple
The average P/S ratio for EXPO's competitors is 2.77, providing a benchmark for relative valuation. Exponent Inc Corp (EXPO) exhibits a P/S ratio of 6.18, which is 123.05% above the industry average. Given its robust revenue growth of 9.58%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of EXPO decreased by 19.90% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 125.09M to 137.07M.
The secondary factor is the Margin Expansion, contributed -1.73%to the performance.
Overall, the performance of EXPO in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
Frequently Asked Questions
Is Exponent Inc (EXPO) currently overvalued or undervalued?
Exponent Inc (EXPO) is now in the Undervalued zone, suggesting that its current forward PE ratio of 32.05 is considered Undervalued compared with the five-year average of 46.68. The fair price of Exponent Inc (EXPO) is between 87.38 to 119.03 according to relative valuation methord. Compared to the current price of 75.02 USD , Exponent Inc is Undervalued By 14.15% .
What is Exponent Inc (EXPO) fair value?
EXPO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Exponent Inc (EXPO) is between 87.38 to 119.03 according to relative valuation methord.
How does EXPO's valuation metrics compare to the industry average?
The average P/S ratio for EXPO's competitors is 2.77, providing a benchmark for relative valuation. Exponent Inc Corp (EXPO) exhibits a P/S ratio of 6.18, which is 123.05% above the industry average. Given its robust revenue growth of 9.58%, this premium appears unsustainable.
What is the current P/B ratio for Exponent Inc (EXPO) as of Jan 08 2026?
As of Jan 08 2026, Exponent Inc (EXPO) has a P/B ratio of 8.70. This indicates that the market values EXPO at 8.70 times its book value.
What is the current FCF Yield for Exponent Inc (EXPO) as of Jan 08 2026?
As of Jan 08 2026, Exponent Inc (EXPO) has a FCF Yield of 3.51%. This means that for every dollar of Exponent Inc’s market capitalization, the company generates 3.51 cents in free cash flow.
What is the current Forward P/E ratio for Exponent Inc (EXPO) as of Jan 08 2026?
As of Jan 08 2026, Exponent Inc (EXPO) has a Forward P/E ratio of 32.05. This means the market is willing to pay $32.05 for every dollar of Exponent Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Exponent Inc (EXPO) as of Jan 08 2026?
As of Jan 08 2026, Exponent Inc (EXPO) has a Forward P/S ratio of 6.18. This means the market is valuing EXPO at $6.18 for every dollar of expected revenue over the next 12 months.